LEXARIA BIOSCIENCE CORP. Investment Income, Net
LEXARIA BIOSCIENCE CORP. (LEXX) reported Investment Income, Net of $0 for the 9-month period ending 2022-05-31, per its 10-Q filed 2022-07-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2022-11-28
- LEXARIA BIOSCIENCE CORP. investment income, net for the quarter ending 2022-05-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. investment income, net for the quarter ending 2022-02-28 was $0.00.
- LEXARIA BIOSCIENCE CORP. investment income, net for the quarter ending 2021-11-30 was $0.00, a 100.00% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. investment income, net for the quarter ending 2021-08-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. investment income, net for fiscal 2021 was -$22.00K, a 134.28% decline from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. investment income, net for fiscal 2020 was $64.18K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2022-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | $0.00 derived: sum of 2 quarters · filed 2022-07-14 | $0.00 10-Q · filed 2022-07-14 | $0.00 derived: sum of 4 quarters · filed 2022-11-28 |
| 2022-02-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | $0.00 10-Q · filed 2022-04-11 | $0.00 derived: sum of 3 quarters · filed 2022-11-28 | $0.00 derived: sum of 4 quarters · filed 2022-11-28 |
| 2021-11-30 | $0.00 10-Q · filed 2022-01-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | $0.00 derived: sum of 3 quarters · filed 2022-11-28 | -$25.00K derived: sum of 4 quarters · filed 2022-11-28 |
| 2021-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $0.00 derived: sum of 2 quarters · filed 2022-11-28 | -$25.00K derived: sum of 3 quarters · filed 2022-11-28 | -$22.00K 10-K · filed 2022-11-28 |
| 2021-05-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-07-14 | -$25.00K derived: sum of 2 quarters · filed 2022-07-14 | -$22.00K 10-Q · filed 2022-07-14 | -$41.61K derived: sum of 4 quarters · filed 2022-07-14 |
| 2021-02-28 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-04-11 | -$22.00K 10-Q · filed 2022-04-11 | -$41.61K derived: sum of 3 quarters · filed 2022-04-11 | |
| 2020-11-30 | $3.00K 10-Q · filed 2022-01-14 | -$16.61K derived: sum of 2 quarters · filed 2022-01-14 | ||
| 2020-08-31 | -$19.61K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $64.18K 10-K · filed 2021-11-29 | ||
| 2020-05-31 | $83.80K 10-Q · filed 2021-07-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |